"I am thinking management is likely pricing a partnership based on success at upcoming trials, but likely having money change hands when the results come in."
That's basically like saying the partnership is for manufacturing and distribution only, and that shareholders will fund the trials to the degree that trial funding requirements exceed govt funding.
News 
Market Data 
Discover 
